Literature DB >> 8029011

Repair of triple helix directed psoralen adducts in human cells.

Z Sandor1, A Bredberg.   

Abstract

Triple helix forming oligonucleotides can direct DNA damaging agents at specific sites in an intact double helix. In our study, triple helix formation was demonstrated in a SV40 based shuttle vector treated with psoralen linked to a 22-mer purine rich oligonucleotide. UVA irradiation caused a covalent linkage of the oligonucleotide through the psoralen to the mutational supF marker gene of the plasmid. After passage in the Jurkat human cell line the recovered vector was analysed in an indicator bacterial strain and mutants were collected. The presence of adducts in the target sequence did not reduce the yield of replicated progeny vector molecules, indicating repair of triple helix associated monoadducts and cross-links. Mutations were highly targeted to a six nucleotide long region of the target sequence. The number of target sequence mutants obtained after triple helix directed psoralen treatment was approximately 160 times higher than with free psoralen. A further investigation of the exact mechanism of the mutational process could make triple helix directed mutagenesis a more useful tool in gene therapy, antiviral therapy, and in studies on DNA repair and genome organisation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8029011      PMCID: PMC308120          DOI: 10.1093/nar/22.11.2051

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  29 in total

Review 1.  Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry.

Authors:  G D Cimino; H B Gamper; S T Isaacs; J E Hearst
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

2.  Psoralen adducts in a shuttle vector plasmid propagated in primate cells: high mutagenicity of DNA cross-links.

Authors:  A Bredberg; N Nachmansson
Journal:  Carcinogenesis       Date:  1987-12       Impact factor: 4.944

3.  Action mechanism of ABC excision nuclease on a DNA substrate containing a psoralen crosslink at a defined position.

Authors:  B Van Houten; H Gamper; S R Holbrook; J E Hearst; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  Repair of psoralen-induced crosslinks in cells multiply infected with SV40.

Authors:  J D Hall
Journal:  Mol Gen Genet       Date:  1982

5.  Sequence-specific cleavage of double helical DNA by triple helix formation.

Authors:  H E Moser; P B Dervan
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

6.  Repair of DNA containing interstrand crosslinks in Escherichia coli: sequential excision and recombination.

Authors:  R S Cole
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

7.  Termination sites of the in vitro nick-translation reaction on DNA that had photoreacted with psoralen.

Authors:  J G Piette; J E Hearst
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

Review 8.  DNA triple-helix formation: an approach to artificial gene repressors?

Authors:  L J Maher
Journal:  Bioessays       Date:  1992-12       Impact factor: 4.345

9.  Wavelength dependence for the photoreversal of a psoralen-DNA cross-link.

Authors:  G D Cimino; Y B Shi; J E Hearst
Journal:  Biochemistry       Date:  1986-05-20       Impact factor: 3.162

10.  Infidelity of DNA synthesis associated with bypass of apurinic sites.

Authors:  R M Schaaper; T A Kunkel; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more
  14 in total

1.  Repairing the Sickle Cell mutation. III. Effect of irradiation wavelength on the specificity and type of photoproduct formed by a 3'-terminal psoralen on a third strand directed to the mutant base pair.

Authors:  Steven L Broitman; Olga Amosova; Jacques R Fresco
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

2.  Processing of targeted psoralen cross-links in Xenopus oocytes.

Authors:  D J Segal; A F Faruqi; P M Glazer; D Carroll
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Sequence-specific targeting and covalent modification of human genomic DNA.

Authors:  E S Belousov; I A Afonina; M A Podyminogin; H B Gamper; M W Reed; R M Wydro; R B Meyer
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

4.  In vivo persistence of DNA triple helices containing psoralen-conjugated oligodeoxyribonucleotides.

Authors:  M Musso; J C Wang; M W Van Dyke
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

5.  Effect of third strand composition on the triple helix formation: purine versus pyrimidine oligodeoxynucleotides.

Authors:  B Faucon; J L Mergny; C Héléne
Journal:  Nucleic Acids Res       Date:  1996-08-15       Impact factor: 16.971

6.  Blocking transcription of the human rhodopsin gene by triplex-mediated DNA photocrosslinking.

Authors:  Z Intody; B D Perkins; J H Wilson; T G Wensel
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

7.  Repair of triplex-directed DNA alkylation by nucleotide excision repair.

Authors:  A Ziemba; L C Derosier; R Methvin; C Y Song; E Clary; W Kahn; D Milesi; V Gorn; M Reed; S Ebbinghaus
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

Review 8.  Repair of DNA lesions associated with triplex-forming oligonucleotides.

Authors:  Joanna Y Chin; Peter M Glazer
Journal:  Mol Carcinog       Date:  2009-04       Impact factor: 4.784

9.  Detection of covalent triplex within human cells.

Authors:  A L Guieysse; D Praseuth; M Grigoriev; A Harel-Bellan; C Hélène
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

10.  Characteristics of triplex-directed photoadduct formation by psoralen-linked oligodeoxynucleotides.

Authors:  P J Bates; V M Macaulay; M J McLean; T C Jenkins; A P Reszka; C A Laughton; S Neidle
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.